High-resolution melting analysis of HPV-16L1 gene methylation: A promising method for prognosing cervical cancer

Clinical Biochemistry

Volumn 48, Issue 13-14, 2015, Pages 855-859

  Qiu, Cui ^a   Zhi, Yanfang ^a   Shen, Yong ^a   Gong, Jiaomei ^a   Li, Ya ^a   Li, Xiaofu ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia; DNA methylation; High resolution melting; HPV 16; L1 gene

Indexed keywords

CAPSID PROTEIN; L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; VIRUS DNA;

ADULT; AGED; CANCER GRADING; DNA DENATURATION; DNA METHYLATION; FEMALE; FLUORESCENCE; GENETICS; HUMAN; MIDDLE AGED; PATHOLOGY; PROGNOSIS; STANDARD; STATISTICAL MODEL; UTERINE CERVICAL NEOPLASMS;

ADULT; AGED; CAPSID PROTEINS; DNA METHYLATION; DNA, VIRAL; FEMALE; FLUORESCENCE; HUMANS; LINEAR MODELS; MIDDLE AGED; NEOPLASM GRADING; NUCLEIC ACID DENATURATION; ONCOGENE PROTEINS, VIRAL; PROGNOSIS; REFERENCE STANDARDS; UTERINE CERVICAL NEOPLASMS;

EID: 84952979791     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2015.05.006     Document Type: Article

References (33)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90.
2. Muñoz N., Bosch F.X., Sd Sanjosé, Herrero R., Castellsagué X., Shah K.V. Epidemiological classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348:518-527.
3. Saslow D., Solomon D., Lawson H.W., Killackey M., Kulasingam S.L., Cain J., et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 2012, 137(4):516-542.
4. Bansal N., Wright J.D., Cohen C.J., Herzog T.J. Natural history of established low grade cervical intraepithelial (CIN 1) lesions. Anticancer Res 2008, 28(3B):1763-1766.
5. Mayrand M.H., Duarte-Franco E., Rodrigues I., Walter S.D., Hanley J., Ferenczy A., et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 2007, 357(16):1579-1588.
6. Castle P.E., de Sanjose S., Qiao Y.L., Belinson J.L., Lazcano-Ponce E., Kinney W. Introduction of human papillomavirus DNA screening in the world: 15 years of experience. Vaccine 2012, 30(Suppl. 5):F117-22.
7. Fernandez A.F., Rosales C., Lopez-Nieva P., Grana O., Ballestar E., Ropero S., et al. The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res 2009, 19(3):438-451.
8. Wiley D.J., Huh J., Rao J.Y., Chang C., Goetz M., Poulter M., et al. Methylation of human papillomavirus genomes in cells of anal epithelia of HIV-infected men. J Acquir Immune Defic Syndr 2005, 39(2):143-151.
9. Balderas-Loaeza A., Anaya-Saavedra G., Ramirez-Amador V.A., Guido-Jimenez M.C., Kalantari M., Calleja-Macias I.E., et al. Human papillomavirus-16 DNA methylation patterns support a causal association of the virus with oral squamous cell carcinomas. Int J Cancer 2007, 120(10):2165-2169.
10. Kalantari M., Villa L.L., Calleja-Macias I.E., Bernard H.U. Human papillomavirus-16 and -18 in penile carcinomas: DNA methylation, chromosomal recombination and genomic variation. Int J Cancer 2008, 123(8):1832-1840.
11. Wentzensen N., Sun C., Ghosh A., Kinney W., Mirabello L., Wacholder S., et al. Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3. J Natl Cancer Inst 2012, 104(22):1738-1749.
12. Bryant D., Tristram A., Liloglou T., Hibbitts S., Fiander A., Powell N. Quantitative measurement of human papillomavirus type 16L1/L2 DNA methylation correlates with cervical disease grade. J Clin Virol 2014, 59(1):24-29.
13. Dimitrakopoulos L., Vorkas P.A., Georgoulias V., Lianidou E.S. A closed-tube methylation-sensitive high resolution melting assay (MS-HRMA) for the semi-quantitative determination of CST6 promoter methylation in clinical samples. BMC Cancer 2012, 12(:486.
14. Migheli F., Stoccoro A., Coppede F., Wan Omar W.A., Failli A., Consolini R., et al. Comparison study of MS-HRM and pyrosequencing techniques for quantification of APC and CDKN2A gene methylation. PLoS One 2013, 8(1):e52501.
15. Sun C., Reimers L.L., Burk R.D. Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer. Gynecol Oncol 2011, 121(1):59-63.
16. Li N., Franceschi S., Howell-Jones R., Snijders P.J., Clifford G.M. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer 2011, 128(4):927-935.
17. Arias-Pulido H., Peyton C.L., Joste N.E., Vargas H., Wheeler C.M. Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol 2006, 44(5):1755-1762.
18. Kalantari M., Karlsen F., Kristensen G., Holm R., Hagmar B., Johansson B. Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis. Int J Gynecol Pathol 1998, 17(2):146-153.
19. Cheung J.L., Cheung T.H., Yu M.Y., Chan P.K. Virological characteristics of cervical cancers carrying pure episomal form of HPV16 genome. Gynecol Oncol 2013, 131(2):374-379.
20. Kraus I., Driesch C., Vinokurova S., Hovig E., Schneider A., von Knebel Doeberitz M., et al. The majority of viral-cellular fusion transcripts in cervical carcinomas cotranscribe cellular sequences of known or predicted genes. Cancer Res 2008, 68(7):2514-2522.
21. Weisenberger D.J., Campan M., Long T.I., Kim M., Woods C., Fiala E., et al. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 2005, 33(21):6823-6836.
22. Frommer M., McDonald L.E., Millar D.S., Collis C.M., Watt F., Grigg G.W., et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 1992, 89(5):1827-1831.
23. Colella S., Shen L., Baggerly K.A., Issa J.P., Krahe R. Sensitive and quantitative universal pyrosequencing methylation analysis of CpG sites. Biotechniques 2003, 35(1):146-150.
24. Wojdacz T.K., Dobrovic A. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res 2007, 35(6):e41.
25. Mirabello L., Schiffman M., Ghosh A., Rodriguez A.C., Vasiljevic N., Wentzensen N., et al. Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia. Int J Cancer 2013, 132(6):1412-1422.
26. Clarke M.A., Wentzensen N., Mirabello L., Ghosh A., Wacholder S., Harari A., et al. Human papillomavirus DNA methylation as a potential biomarker for cervical cancer. Cancer Epidemiol Biomarkers Prev 2012, 21(12):2125-2137.
27. Mirabello L., Sun C., Ghosh A., Rodriguez A.C., Schiffman M., Wentzensen N., et al. Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population. J Natl Cancer Inst 2012, 104(7):556-565.
28. Oka N., Kajita M., Nishimura R., Ohbayashi C., Sudo T. L1 gene methylation in high-risk human papillomaviruses for the prognosis of cervical intraepithelial neoplasia. Int J Gynecol Cancer 2013, 23(2):235-243.
29. Kalantari M., Lee D., Calleja-Macias I.E., Lambert P.F., Bernard H.U. Effects of cellular differentiation, chromosomal integration and 5-aza-2'-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines. Virology 2008, 374(2):292-303.
30. Kalantari M., Chase D.M., Tewari K.S., Bernard H.U. Recombination of human papillomavirus-16 and host DNA in exfoliated cervical cells: a pilot study of L1 gene methylation and chromosomal integration as biomarkers of carcinogenic progression. J Med Virol 2010, 82(2):311-320.
31. Yoder J.A., Walsh C.P., Bestor T.H. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet 1997, 13(8):335-340.
32. Tao Q., Robertson K.D. Stealth technology: how Epstein-Barr virus utilizes DNA methylation to cloak itself from immune detection. Clin Immunol 2003, 109(1):53-63.
33. Verhoef V.M., Bosgraaf R.P., van Kemenade F.J., Rozendaal L., Heideman D.A., Hesselink A.T., et al. Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial. Lancet Oncol 2014, 15(3):315-322.